Caitlin Crosier

Prisma Health

Papers

1

Total Citations

2

H-Index

1

About

Caitlin Crosier is a surgical outcomes researcher whose work focuses on optimizing perioperative care and reducing opioid dependence in hernia repair. Her most-cited study, "Impact of methocarbamol on opioid use after ventral incisional hernia repair" (2023), investigates non-opioid adjuncts for pain management, reflecting a growing priority in surgical practice to mitigate opioid-related risks. With 2 citations to date, this work contributes to evidence-based strategies for multimodal analgesia, directly addressing the opioid crisis by exploring alternatives like methocarbamol. Crosier’s research sits at the intersection of surgical innovation and public health, aiming to improve patient recovery while minimizing narcotic exposure. Her findings offer practical insights for surgeons and anesthesiologists, highlighting the potential of muscle relaxants in postoperative protocols. As a rising voice in surgical outcomes, Crosier’s work underscores the importance of data-driven approaches to pain management, making her a notable contributor to the evolving landscape of hernia surgery and opioid stewardship. Her ongoing efforts promise to shape safer, more effective recovery pathways for patients undergoing complex abdominal wall repairs.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Impact of methocarbamol on opioid use after ventral incisional hernia repair
2 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Prisma Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago